Thyrotropin serum concentrations in patients with papillary thyroid microcancers

Thyroid

Volumn 20, Issue 4, 2010, Pages 389-392

  Gerschpacher, Marion ^a   Göbl, Christian ^a   Anderwald, Christian ^a   Gessl, Alois ^a   Krebs, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RETROSPECTIVE STUDY; SERUM; THYROID CANCER; THYROID PAPILLARY CARCINOMA; THYROTROPIN BLOOD LEVEL;

ADULT; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; THYROTROPIN;

EID: 77952385766     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0139     Document Type: Article

References (24)

1. Sherman SI 2003 Thyroid carcinoma. Lancet 361:501-511.
2. Hegedus L, Bonnema SJ, Bennedbaek FN 2003 Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102-132.
3. Shibata Y, Yamashita S, Masyakin VB, Panasyuk GD, Nagataki S 2001 15 years after Chernobyl: new evidence of thyroid cancer. Lancet 358:1965-1966. (Pubitemid 34072882)
4. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:1-33.
5. Sanders LE, Cady B 1998 Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 133:419-425. (Pubitemid 28193527)
6. Jonklaas J, Nsouli-Maktabi H, Soldin SJ 2008 Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid 18:943-952.
7. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H 2008 Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 93:809-814.
8. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA 2006 Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investgated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295-4301.
9. Lim AK, Daykin J, Holder R, Sheppard MC, Franklyn JA 1998 Measurement of serum TSH in the investigation of patients presenting with thyroid enlargement. QJM 91:687-689.
10. Küçük NO, Tari P, Tokmak E, Aras G 2007 Treatment for microcarcinoma of the thyroid-clinical experience. Clin Nucl Med 32:279-281.
11. Biscolla RP, Ugolini C, Sculli M, Bottici V, Castagna MG, Romei C, Cosci B, Molinaro E, Faviana P, Basolo F, Miccoli P, Pacini F, Pinchera A, Elisei R 2004 Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behaviour. Thyroid 14:946-952.
12. Harach HR, Franssila KO, Wasenius VM 1985 Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 56:531-538.
13. Maes M, Mommen K, Hendrickx D, Peeters D, D'Hondt P, Ranjan R, De Mayer F, Scharpé S 1997 Components of biological variation, including seasonality, in blood concentrations of TSH, TT3, FT4, PRL, cortisol and testosterone in healthy volunteers. Clin Endocrinol 46:587-598.
14. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ 1992 Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139-1147.
15. Lim DJ, Baek KH, Lee YS, Park WC, Kim MK, Kang MI, Jeon HM, Lee JM, Yun-Cha B, Lee KW, Son HY, Kang SK 2007 Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma. Thyroid 17:883-888.
16. Nikiforov YE 2008 Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 21 Suppl 2:37-43 Review.
17. Nikiforova MN, Nikiforov YE 2008 Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn 8:83-95.
18. Derwahl M, Broecker M, Kraiem Z 1999 Clinical review 101: thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. J Clin Endocrinol Metab 84:829-834.
19. Farid NR, Shi Y, Zou M 1994 Molecular basis of thyroid cancer. Endocr Rev 15:202-232.
20. Kanamori A, Abe Y, Yajima Y, Manabe Y, Ito K 1989 Epidermal growth factor receptors in plasma membranes of normal and diseased human thyroid glands. J Clin Endocrinol Metab 68:899-903.
21. Haugen DRF, Akslen LA, Varhaug JE 1992 Expression of c-erb B-2 protein in papillary thyroid carcinomas. Br J Cancer 63:832-837.
22. Belfiore A, Gangemi P, Costantino A, Russo G, Santonocito GM, Ippolito O, Di Renzo MF, Comoglio P, Fiumara A, Vigneri R 1997 Negative/low expression of the Met/HGFR identifies papillary thyroid carcinomas with high risk of distant metastases. J Clin Endocrinol Metab 82:2322-2328.
23. Dumont JE, Lamy F, Roger P, Maenhaut C 1992 Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 72:667-697.
24. Milazzo G, La Rosa GL, Catalfamo R, Vigneri R, Belfiore A 1992 Effect of TSH in human thyroid cells. Evidence for both mitogenic and antimitogenic effects. J Cell Biochem 49:231-238.